Boswellia for osteoarthritis

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the benefits and harms of boswellia extracts (BEs), or formulations containing BEs for osteoarthritis.

This is a protocol.

Published:

13 October 2022

Authors:

Wang Z, Singh A, Jones G, Aitken D, Laslett LL, Hussain S, García-Molina P, Ding C, Antony B

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Wang Z, Singh A, Jones G, Aitken D, Laslett LL, Hussain S, García-Molina P, Ding C, Antony B. Boswellia for osteoarthritis (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 10. Art. No.: CD014969. DOI: 10.1002/14651858.CD014969.